NeoGenomics
NeoGenomics Names Warren Stone Chief Executive Officer
NeoGenomics announced a leadership change on October 5, 2026. NeoGenomics named President and COO Warren Stone CEO effective January 4, 2027, with Tony Zook becoming Executive Chair and the company emphasizing strategic continuity.
What changed
Warren Stone was named Chief Executive Officer. Tony Zook, the current CEO, will assume the role of Executive Chair when Stone becomes CEO and will continue to work in close alignment with Stone and the Board.
- Leader: Warren Stone
- Role: Chief Executive Officer
- Effective: January 4, 2027
- Announcement date: October 5, 2026
Leadership background
Stone, 54, has more than three decades of life sciences and diagnostics leadership experience, including senior roles at Ortho Clinical Diagnostics and MilliporeSigma/Merck KGaA. Since joining NeoGenomics in 2022, he has held roles of increasing responsibility, including President of Clinical Services and Chief Commercial Officer, most recently serving as President and Chief Operating Officer.
The mandate
In the release, Zook said the transition emphasizes strategic continuity and a consistent strategy for durable, profitable growth at NeoGenomics, and he cited Stone’s work on commercial expansion and customer impact, new product introductions, and Lab of the Future initiatives.
Why this matters for GTM teams
Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.
Source and methodology
This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.
Primary source: NeoGenomics leadership announcement.
Related Reports
Asembia Appoints David Skomo Chief Executive Officer
Asembia appointed David Skomo as CEO, succeeding co-founder Lawrence Irene, and said he will focus on strengthening the company’s commercial capabilities, technology platform, and pharmacy services.
Lassila and Tikanoja Appoints Ari-Pekka Määttänen President and CEO
Lassila and Tikanoja appointed Ari-Pekka Määttänen, CEO of Fintoil Oy, as President and CEO from May 1, 2027, succeeding Eero Hautaniemi to lead the circular economy company’s next phase of growth.
Sciensus Appoints James Tugendhat Chief Executive Officer
Sciensus has appointed James Tugendhat OBE, most recently Group CEO of HC-One, as Chief Executive Officer, taking over from interim CEO Gordon Cox.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started


